Hat mitgewirkt an:
-
Mechanismen der vaskulären und valvulären Krankheitsprogression : therapeutische Implikationen
-
Pathomechanismen der In-Stent-Restenose
-
Efficacy and safety of sacubitril/valsartan in an outpatient setting: A single-center real-world retrospective study in HFrEF patients with focus on possible predictors of clinical outcome
-
Diltiazem as a cyclosporine A-sparing agent in heart transplantation: Benefits beyond dose reduction